胎儿心动过缓与长QT综合征的产前表现
回顾性分析22例产前窦性心动过缓、2:1房室传导阻滞或室性心动过速胎儿,排除母体抗体和重大心脏结构异常。13例基因确诊长QT综合征,最常见为KCNQ1变异。持续窦性心动过缓而无结构异常者中长QT综合征最常见,产前基因检测有助于咨询与管理。
要点
- 无结构异常和自身免疫病的持续性窦性心动过缓胎儿,应高度警惕长QT综合征。
- 长QT综合征胎儿可表现为窦性心动过缓、2:1房室传导阻滞或室性心动过速。
- 无长QT综合征家族史并不能排除胎儿长QT综合征。
核心结论
- 在无重大先天性心脏病或自身免疫病且表现为持续性窦性心动过缓的胎儿中,最常见的病因是长QT综合征。
- 产前基因检测可为父母咨询和妊娠管理提供依据。
研究设计与样本
- 共纳入22例表现为窦性心动过缓、非免疫性2:1房室传导阻滞或室性心动过速的胎儿。
- 排除母体抗Ro/抗La抗体阳性、房性早搏受阻和重大先天性心脏病病例。
- 窦性心律中位胎心率120(范围100–139)次/分,中位Z值-3.04(范围-4.98至-0.91)。
关键影像表现/征象
- 22例中窦性心动过缓16例、2:1房室传导阻滞2例、窦性心动过缓合并2:1房室传导阻滞2例、室性心动过速2例。
- 13例长QT综合征基因阳性,其中KCNQ1变异8例、KCNH2变异2例、KCNE1变异1例、SCN5A变异1例、CALM2变异1例。
- 脉冲多普勒测量左心室等容舒张时间及其占心动周期比例用于估算QT间期。
诊断标准与关键数值
- 胎儿心动过缓定义为心室率低于同孕周均值2个标准差以上。
- 在13例基因确诊长QT综合征病例中,N-LVIRT持续高于阈值者2例,LVIRT持续高于阈值者6例。
- 14例进行了基因检测,其中12例为产前检测。
临床应用与阅片要点
- 面对持续性窦性心动过缓胎儿时,即使无家族史,也应评估长QT综合征可能并考虑产前基因检测。
- N-LVIRT和LVIRT在多数基因确诊病例中未超过阈值,不能作为排除长QT综合征的可靠指标。
- 胎儿超声心动图发现2:1房室传导阻滞或室性心动过速时,应将长QT综合征纳入鉴别诊断。
局限性
- 回顾性研究。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Fetal bradycardia may be defined as a ventricular rate more than 2 SD below the gestational-age-specific mean. Sinus bradycardia, functional 2:1 atrioventricular block (AVB) and/or polymorphic ventricular tachycardia (VT) are recognized as potential presentations of fetal long QT syndrome (LQTS). The objectives of this study were to describe the associations with LQTS and outcomes of fetuses presenting with isolated sinus bradycardia, 2:1 AVB or VT.
METHODS: This was a retrospective review of all cases presenting with sinus bradycardia, non-immune mediated 2:1 AVB or VT on referral to our tertiary fetal cardiology center between January 2018 and November 2023. Cases with maternal anti-Ro/anti-La antibodies, blocked atrial ectopic beats or major congenital heart disease were excluded. Data were collected on patient demographics, fetal echocardiography findings, clinical genetic results, family screening and postnatal outcome. The left ventricular isovolumetric relaxation time (LVIRT) and LVIRT normalized as a proportion of cycle length (N-LVIRT) were derived using pulsed-wave Doppler tracings to estimate the QT interval.
RESULTS: In total, 22 fetuses were included in the study, with a presenting rhythm of sinus bradycardia in 16, 2:1 AVB in two, both sinus bradycardia and 2:1 AVB in two and VT in two. None had a family history of LQTS. Genetic testing was performed in 14 cases of which 12 were tested prenatally. There were 13 cases with a positive LQTS genotype (eight KCNQ1, one KCNE1, two KCNH2, one SCN5A and one CALM2). Median presenting fetal heart rate (FHR) and FHR Z-score in sinus rhythm was 120 (range, 100-139) bpm and -3.04 (range, -4.98 to -0.91), respectively. In the 13 cases with genetically confirmed LQTS, N-LVIRT and LVIRT were persistently above threshold in two and six cases, respectively.
CONCLUSIONS: The most common finding in fetuses with persistent sinus bradycardia without major congenital heart disease or autoimmune disease is LQTS. Prenatal genetic testing enables tailored parental counseling and management of the pregnancy. Although N-LVIRT and LVIRT were not above the threshold values in most cases, they remain important measures for investigation in future studies. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Chivers, Zidere, Vigneswaran, et al. Prenatal presentation of fetal bradycardia and long QT syndrome. Ultrasound Obstet Gynecol. 2026. PMID: 41482982. doi:10.1002/uog.70132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。